Cimex

Cimex was a Swiss pharmaceutical company specializing in the development and manufacture of complex generics and niche pharmaceutical products. Based in Liesberg, the company was widely recognized for its expertise in advanced galenical formulation technologies, particularly solid slow-release dosage forms and multi-unit pellet systems (MUPS). Cimex provided a comprehensive range of services to the generics industry, including product development, registration, and contract manufacturing. In 2004, the company was acquired by Schweizerhall (now Acino), and its operations were subsequently integrated into the Acino Group. Today, the legacy of Cimex lives on through Acino's continued focus on high-quality, complex drug delivery systems for global markets.